Literature DB >> 1637178

The heparin binding site of human extracellular-superoxide dismutase.

T Adachi1, T Kodera, H Ohta, K Hayashi, K Hirano.   

Abstract

Extracellular-superoxide dismutase (EC-SOD) is a secretory glycoprotein that is major SOD isozyme in extracellular fluids. We revealed the possible structure of the carbohydrate chain of serum EC-SOD with the serial lectin affinity technique. The structure is a biantennary complex type with an internal fucose residue attached to asparagine-linked N-acetyl-D-glucosamine and with terminal sialic acid linked to N-acetyllactosamine. EC-SOD in plasma is heterogeneous with regard to heparin affinity and can be divided into three fractions: A, without affinity; B, with intermediate affinity; and C, with high affinity. It appeared that this heterogeneity is not dependent on the carbohydrate structure upon comparison of EC-SOD A, B, and C. No effect of the glycopeptidase F treatment of EC-SOD C on its heparin affinity supported the results. A previous report showed that both lysine and arginine residues probably at the C-terminal end, contribute to heparin binding. Recombinant EC-SOD C treated with trypsin or endoproteinase Lys C, which lost three lysine residues (Lys-211, Lys-212, and Lys-220) or one lysine residue (Lys-220) at the C-terminal end, had no or weak affinity for the heparin HPLC column, respectively. The proteinase-treated r-EC-SOD C also lost triple arginine residues which are adjacent to double lysine residues. These results suggest that the heparin-binding site may occur on a "cluster" of basic amino acids at the C-terminal end of EC-SOD C. EC-SOD is speculated to be primarily synthesized as type C, and types A and B are probably the result of secondary modifications. It appeared that the proteolytic cleavage of the exteriorized lysine- and arginine-rich C-terminal end in vivo is a more important contributory factor to the formation of EC-SOD B and/or EC-SOD A.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637178     DOI: 10.1016/0003-9861(92)90654-f

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  16 in total

1.  Human extracellular superoxide dismutase is a tetramer composed of two disulphide-linked dimers: a simplified, high-yield purification of extracellular superoxide dismutase.

Authors:  T D Oury; J D Crapo; Z Valnickova; J J Enghild
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer.

Authors:  Zita A Sibenaller; Jessemae L Welsh; Changbin Du; Jordan R Witmer; Hannah E Schrock; Juan Du; Garry R Buettner; Prabhat C Goswami; John A Cieslak; Joseph J Cullen
Journal:  Free Radic Biol Med       Date:  2014-02-07       Impact factor: 7.376

3.  The folding of human active and inactive extracellular superoxide dismutases is an intracellular event.

Authors:  Steen V Petersen; Torsten Kristensen; Jane S Petersen; Lasse Ramsgaard; Tim D Oury; James D Crapo; Niels C Nielsen; Jan J Enghild
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

4.  Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.

Authors:  Melissa L T Teoh; Matthew P Fitzgerald; Larry W Oberley; Frederick E Domann
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

5.  Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.

Authors:  Fei Gao; Jeffrey R Koenitzer; Jacob M Tobolewski; Dianhua Jiang; Jiurong Liang; Paul W Noble; Tim D Oury
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

6.  Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis.

Authors:  M L Teoh-Fitzgerald; M P Fitzgerald; W Zhong; R W Askeland; F E Domann
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

7.  Rational design of a secreted enzymatically inactive mutant of extracellular superoxide dismutase.

Authors:  Adam J Case; James J Mezhir; Brianne R O'Leary; Jennifer E Hrabe; Frederick E Domann
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

8.  Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.

Authors:  T Adachi; H Yamada; Y Yamada; N Morihara; N Yamazaki; T Murakami; A Futenma; K Kato; K Hirano
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

9.  The cellular distribution of extracellular superoxide dismutase in macrophages is altered by cellular activation but unaffected by the naturally occurring R213G substitution.

Authors:  Randi H Gottfredsen; David A Goldstrohm; John M Hartney; Ulrike G Larsen; Russell P Bowler; Steen V Petersen
Journal:  Free Radic Biol Med       Date:  2014-02-07       Impact factor: 7.376

10.  The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities.

Authors:  Steen V Petersen; Dorte Aa Olsen; John M Kenney; Tim D Oury; Zuzana Valnickova; Ida B Thøgersen; James D Crapo; Jan J Enghild
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.